Skip to main content

Table 2 Recurrences between supervised and unsupervised treatment groups with 180-day follow-up period

From: Evaluation of the effect of supervised anti-malarial treatment on recurrences of Plasmodium vivax malaria

  Total Supervised Unsupervised P
  n = 117 n = 56 (47.8%) n = 61 (52.2%)  
Recurrence in 180 days (n/N) 32/117 (27%) 10/56 (18%) 22/61 (36%) 0.027
Number of recurrences (n/N) 0.07
 1 18/32 (56%) 8/10 (80%) 10/22 (46%)  
 ≥ 2 14/32 (43.8%) 2/10 (20%) 12/22 (54%)   
Time to first recurrence (d) (n/N) 0.04
 ≤ 60 6/32 (19%) 1/10 (10%) 5/22 (23%)  
 61–90 14/32 (44%)  2/10 (20%) 12/22 (54%)  
 91–180 12/32 (37 %) 7/10 (70%) 5/22 (23%)  
  1. The denominator for the number of recurrences and time to recurrence is the number of recurrences observed in each group